#59 BDNF: a Potential Biomarker of Overactive Bladder
Antunes-Lopes T1, Pinto R1, Barros S2, Diniz P1, Martins-Silva C1, Duarte-Cruz C2, Cruz F11. Department of Urology, Hospital de São João, Porto, 2. Experimental Biology Department, Faculty of Medicine, University of Porto
#60 Brain derived neurotrophic factor (BDNF) is not a valuable biomarker for diagnosing detrusor overactivity.
Bhide A A1, Gopalan V1, Cartwright R1, Digesu G A1, Puccini F1, Fernando R1, Khullar V11. Imperial College London
#61 ELEVATION OF SERUM HEPATIC GROWTH FACTOR AND NERVE GROWTH FACTOR IN PATIENTS WITH OVERACTIVE BLADDER IMPLIES NERVE FIBERS INCREASING IN URINARY BLADDER
Liu H1, Kuo H21. Department of Urology, Buddhist Tzu Chi General Hospital and Institute of Pharmacology and Toxicology, Tzu Chi University, Hualien, Taiwan, 2. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
#62 URINARY LACTOFERRIN AS A PROMISING, NEW, IMPROVED SURROGATE MARKER FOR URINARY TRACT INFECTION.
Gill K1, Brenton T2, Kupelian A1, Horsley H3, Sathiananthamoorthy S1, Collins L4, Malone-Lee J11. University College London (UCL), UK, 2. Brighton University Medical School, UK, 3. Royal Veterinary College, UK, 4. University of Southamptom, UK
#63 Does detrusor overactivity make a difference in women with OAB symptoms?
Jimenez Cidre M A1, López-Fando L1, Esteban Fuertes M2, Prieto Chaparro L3, Castro Diaz D4, Franco de Castro A5, Arlandis Guzman S6, Salinas Casado J7, Gutierrez Ruiz C8, Ifu G91. Department of Urology. Hospital Ramón y Cajal, Madrid, 2. Department of Urology. Hospital de Parapléjicos, Toledo, 3. Department of Urology. Hospital de Elche, Alicante, 4. Department of Urology. Hospital Universitario de Canarias, Tenerife, 5. Department of Urology. Hospital Clinic i Provincial, Barcelona, 6. Department of Urology. Hospital La Fe, Valencia, 7. Department of Urology. Hospital Clinico San Carlos, Madrid, 8. Department of Urology. Fundación Puigvert, Barcelona, 9. Group of Investigation in Functional Urology and Urodynamics
#64 Etiology and management of acute urinary retention in female patients.
Faruqui N1, Nadeem M1, Yasin T11. Aga Khan University
#65 Efficacy of tamsulosin OCAS 0.4 mg in female with lower urinary tract symptoms: A randomized, double-blind, placebo controlled trial
Helmy H11. Tanta University, Faculty of Medicine, Tanta, Egypt
#66 The effect of desmopressin combined with anticholinergic on daytime frequency in female patients with overactive bladder
Kim H1, Lee S H21. Dep. of Urology, Kangdong Sacred Heart Hospital,Hallym University, Seoul, Korea, 2. Department of Urology, Chuncheon Sacred Heart Hospital, Hallym University
#67 The therapeutic effects of orally solifenacin combined with pelvic floor muscle exercises in treatment of female overactive bladder
Jin Y1, Song E1, Lv L1, Li D11. The Harbin 211 Hospital
#68 The Potent and Selective Beta3-adrenoceptor Agonist Mirabegron Improves Patient-reported Outcomes in Overactive Bladder–Results from Two Phase III Studies
Nitti V1, Herschorn S2, Auerbach S3, Khullar V4, Amarenco G5, Blauwet M B6, Boerrigter P7, Hakimi Z8, Siddiqui E9, Martin N101. NYU Langone Medical Center, Department of Urology, New York, NY, USA, 2. University of Toronto, Division of Urology, Toronto, Canada, 3. Hoag Memorial Presbyterian Hospital, Newport Beach, CA, USA, 4. St Mary’s Hospital, Imperial College, Urogynaecology Department, London, UK, 5. Department of Neurologic Rehabilitation, Urodynamic and Neurophysiology Laboratory, Hôpital Rothschild, Assistance Publique-Hôpitaux de Paris, Paris, France, 6. Astellas Pharma Global Development, Inc., Biostatistics, Deerfield, IL, USA, 7. Astellas Pharma Global Development EU, Leiderdorp, The Netherlands, 8. Astellas Pharma Europe, Leiderdorp, The Netherlands, 9. Astellas Pharma Europe Ltd, Staines, Middlesex, UK, 10. Astellas Scientific and Medical Affairs, Inc. Deerfield, IL, USA
#69 Functional brain activity and white matter structure are impaired in elderly urge-incontinent subjects compared to normal control.
Tadic S1, Griffiths D1, Murrin A1, Schaefer W1, Clarkson B1, Resnick N11. University of Pittsburgh, Department of Medicine, Division of Geriatrics
#70 The somatic and autonomic innervation of the clitoris; preliminary evidence of sexual dysfunction after minimal invasive slings
Bekker M1, Hogewoning K1, Wallner C2, Elzevier H1, deRuiter M31. Dept of Urology, Leiden University Medical Center, 2. Dept of Anatomy, Amsterdam Medical Center, 3. Dept of Anatomy, Leiden University Medical Center
#71 Detection of urinary brain derived neurotrophic factor in patients with benign prostatic hyperplasia after surgical treatment and its correlation with the change of overactive bladder symptom
Xu K1, Hu H1, Wang D1, Wang X11. Department of Urology, Peking University People’s Hospital, Peking University Health Science Center
#72 Thoracic epidurally administrated bupivacaine affects urethral sphincter tonus in women after open renal surgery
Burkhard F C1, Metzger T1, Mordasini L1, Wuethrich P Y21. University Hospital Bern, Department of Urology, Bern, Switzerland, 2. University Hospital Bern, Department of Anesthesiology and Pain Treatment, Bern, Switzerland
#73 INCREASED RISK OF LARGE POSTVOID RESIDUAL URINE AND LOWER LONG-TERM SUCCESS RATE IN FRAIL PATIENTS 70 YEARS AND OLDER AFTER INTRAVESICAL ONABOTULINUMTOXIN A INJECTION FOR REFRACTORY IDIOPATHIC DETRUSOR OVERACTIVITY
Liao C1, Lin V C2, Kuo H31. Department of Urology, Cardinal Tien Hospital and Fu-Jen University, New Taipei City, Taiwan, 2. Department of Urology, E-Da Hospital, Kaohsiung, Taiwan, 3. Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University, Hualien, Taiwan
#74 Modified “Remeex” re-adjustable sling procedure: 2 years follow up – outcomes and safety profiles.
Kaplan E11. Center for Advanced Gynecologic Surgery